(Reuters) -Researchers monitoring the brain activity of a patient with a severe binge-eating problem reported that Eli Lilly's GLP-1 weight-loss drug appeared to temporarily suppress food-craving ​signals in the "reward center" of the brain. These are the first direct measurements of brain activity ‌in a person receiving tirzepatide, sold as Mounjaro for diabetes and Zepbound for weight loss, shedding light on the treatment's impact on so-called ‌food noise.

JOHANNESBURG, March 25 (Reuters) - Novo Nordisk is cutting South African prices of its weight-loss drug Wegovy for a second time since it launched ‌in August, local executives said on Wednesday, pointing to fierce competition in ‌a market led by rival Eli Lilly. The Danish drugmaker launched Wegovy in South Africa in August, when reference ​pricing was uncertain due to talks with the U.

Picking your fantasy vehicle is an interesting excursion, whether you are charmed by extravagance, execution, or state of the art innovation. Every choice